Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

WHO Halts Use of Euvax B Vaccine for Hepatitis B (Vietnam)

This article was originally published in PharmAsia News

Executive Summary

The World Health Organization (WHO) has suspended the use of the Euvax B vaccine for hepatitis B worldwide following the deaths of three infants in Vietnam. The vaccine was made by LG company in Korea but reportedly was imported without verification into Vietnam. A government group is investigating the cases and includes representatives of the National Institute of Hygiene and Epidemiology, the Expanded Programme for Immunization, the National Hospital of Pediatrics, the WHO, and UNICEF. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066241

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel